AbbVie is a global research-based biopharmaceutical company that develops and commercializes advanced therapies across immunology, neuroscience, oncology, and aesthetics to treat complex and serious diseases. The company generates revenues through worldwide sales of pharmaceutical products and biologics to physicians, healthcare providers, managed care organizations, and government agencies, primarily through independent wholesale distributors and specialty pharmacies; key marketed products include Skyrizi and Rinvoq for autoimmune conditions, Vraylar for psychiatric disorders, targeted oncology therapies such as Imbruvica and Venclexta, and aesthetics products including Botox Cosmetic and Juvederm. AbbVie competes through technological innovation, patent protection, and regulatory exclusivity, with its competitive position supported by a diversified portfolio across multiple therapeutic areas and a global manufacturing and commercial infrastructure serving markets worldwide.